<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-037747</identifier>
<setSpec>0009-739X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Extra-adrenal pheochromocytoma: update of the most controversial features. A propos of two cases</dc:title>
<dc:description xml:lang="en">Pheochromocytomas are uncommon neuroendocrine tumors. They are usually symptomatic and sporadic and are generally located in the adrenal medulla. We present two cases of extra-adrenal nonfunctional pheochromocytomas located in the retro peritoneum. The tumors were apparently benign and sporadic and were not associated with other neoplasms or hereditary diseases. Ultrasonography, computed axial tomography and magnetic resonance imaging were performed before complete excision of the tumors using open abdominal surgery. Several immunohistochemical techniques were performed to reach the definitive diagnosis. After 8 and 14 months of follow-up, there is no evidence of recurrence or other syndromes. As a consequence of these two cases, we performed review of the literature on the topic, focussing on the most controversial areas (AU)</dc:description>
<dc:creator>González, Juan I</dc:creator>
<dc:creator>Clement, José J</dc:creator>
<dc:creator>Angoso, María</dc:creator>
<dc:creator>Angoso, Fernando</dc:creator>
<dc:creator>García, Juan A</dc:creator>
<dc:creator>Prado, Ángel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los feocromocitomas son tumores neuroendocrinospoco frecuentes, habitualmente sintomáticos y en la mayoría de los casos esporádicos, que se suelen localizar en la médula suprarrenal. Presentamos 2 casos de feocromocitoma extraadrenal no funcionan-te localizados en el retroperitoneo, aparentemente benignos, esporádicos y no asociados con otras neoplasias endocrinas ni enfermedades hereditarias. Empleamos ecografía, tomografía computarizada y resonancia magnética antes de la escisión completa del tumor por vía abdominal abierta, así como diversas técnicas inmunohistoquímicas para llegar al diagnóstico definitivo. Tras 8 y 14 meses de seguimiento no hay evidencia de recidiva de la enfermedad ni de aparición de otros síndromes. Como consecuencia de estos casos, llevamos a cabo una revisión bibliográfica centrándonos en los puntos más controvertidos (AU)</dc:description>
<dc:source>Cir. Esp. (Ed. impr.);77(3): 166-169, mar. 2005. ilus, tab</dc:source>
<dc:identifier>ibc-037747</dc:identifier>
<dc:title xml:lang="es">Feocromocitoma extraadrenal: actualización de los aspectos más controvertidos. A propósito de dos casos</dc:title>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10868^s22016</dc:subject>
<dc:subject>^d10421^s22012</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d10868^s22009</dc:subject>
<dc:subject>^d7991^s22045</dc:subject>
<dc:subject>^d10421^s22016</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d30912^s22045</dc:subject>
<dc:subject>^d10421^s22009</dc:subject>
<dc:subject>^d5^s29166</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d5^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200503</dc:date>
</metadata>
</record>
</ibecs-document>
